Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation

Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation

Abstract Background The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity early after renal transplantation. PTDM diagnosed with an oral glucose to...

Full description

Bibliographic Details
Main Authors: Amin M. Ussif, Anders Åsberg, Thea Anine Strøm Halden, Espen Nordheim, Anders Hartmann, Trond Jenssen
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Nephrology
Subjects:
Renal transplantation
Post-transplantation diabetes mellitus
Diagnosis
Oral glucose tolerance test
HbA1c
Online Access:http://link.springer.com/article/10.1186/s12882-018-1171-3

Internet

http://link.springer.com/article/10.1186/s12882-018-1171-3

Similar Items